Association and predictive value analysis for resting heart rate and diabetes mellitus on cardiovascular autonomic neuropathy in general population

Zi-Hui Tang, Fangfang Zeng, Zhongtao Li, Linuo Zhou, Zi-Hui Tang, Fangfang Zeng, Zhongtao Li, Linuo Zhou

Abstract

Background: The purpose of this study was to evaluate the predictive value of DM and resting HR on CAN in a large sample derived from a Chinese population.

Materials and methods: We conducted a large-scale, population-based, cross-sectional study to explore the relationships of CAN with DM and resting HR. A total of 387 subjects were diagnosed with CAN in our dataset. The associations of CAN with DM and resting HR were assessed by a multivariate logistic regression (MLR) analysis (using subjects without CAN as a reference group) after controlling for potential confounding factors. The area under the receiver-operating characteristic curve (AUC) was used to evaluate the predictive performance of resting HR and DM.

Results: A tendency toward increased CAN prevalence with increasing resting HR was reported (P for trend <0.001). MLR analysis showed that DM and resting HR were very significantly and independently associated with CAN (P < 0.001 for both). Resting HR alone or combined with DM (DM-HR) both strongly predicted CAN (AUC = 0.719, 95% CI 0.690-0.748 for resting HR and AUC = 0.738, 95% CI 0.710-0.766 for DM-HR).

Conclusion: Our findings signify that resting HR and DM-HR have a high value in predicting CAN in the general population.

Figures

Figure 1
Figure 1
Receiver-operating characteristic curves showed the performance of resting heart rate (HR), diabetes (DM), and categorical variable of DM-HR in predicting cardiovascular autonomic neuropathy (CAN) prevalence in this dataset. The 95% confidence interval (CI) is given in parentheses. AUC represents area under the curve. HR: AUC = 0.719, 95% CI 0.690–0.748, P < 0.001; DM: AUC = 0.589, 95% CI 0.556–0.622, P < 0.001; DM-HR: AUC = 0.738, 95% CI 0.710–0.766, P < 0.001.

References

    1. Chen L, Magliano DJ, Zimmet PZ. The worldwide epidemiology of type 2 diabetes mellitus—present and future perspectives. Nature Reviews Endocrinology. 2012;8(4):228–236.
    1. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27(5):1047–1053.
    1. Hazari MA, Khan RT, Reddy BR, Hassan MA. Cardiovascular autonomic dysfunction in type 2 diabetes mellitus and essential hypertension in a South Indian population. Neurosciences. 2012;17:173–175.
    1. Kuehl M, Stevens MJ. Cardiovascular autonomic neuropathies as complications of diabetes mellitus. Nature Reviews Endocrinology. 2012;8:405–416.
    1. Spallone V, Ziegler D, Freeman R, et al. Cardiovascular autonomic neuropathy in diabetes: clinical impact, assessment, diagnosis, and management. Diabetes/Metabolism Research and Reviews. 2011;27(7):639–653.
    1. Garruti G, Giampetruzzi F, Vita MG, et al. Links between metabolic syndrome and cardiovascular autonomic dysfunction. Experimental Diabetes Research. 2012;2012:9 pages.615835
    1. Laitinen T, Lindström J, Eriksson J, et al. Cardiovascular autonomic dysfunction is associated with central obesity in persons with impaired glucose tolerance. Diabetic Medicine. 2011;28(6):699–704.
    1. Iodice V, Low DA, Vichayanrat E, Mathias CJ. Cardiovascular autonomic dysfunction in MSA and Parkinson’s disease: similarities and differences. Journal of the Neurological Sciences. 2011;310(1-2):133–138.
    1. Ziegler D, Zentai C, Perz S, et al. Selective contribution of diabetes and other cardiovascular risk factors to cardiac autonomic dysfunction in the general population. Experimental and Clinical Endocrinology and Diabetes. 2006;114(4):153–159.
    1. Kamphuis MH, Geerlings MI, Dekker JM, et al. Autonomic dysfunction: a link between depression and cardiovascular mortality? The FINE Study. European Journal of Cardiovascular Prevention and Rehabilitation. 2007;14(6):796–802.
    1. Maser RE, Lenhard MJ. Cardiovascular autonomic neuropathy due to diabetes mellitus: clinical manifestations, consequences, and treatment. Journal of Clinical Endocrinology and Metabolism. 2005;90(10):5896–5903.
    1. Vinik AI, Ziegler D. Diabetic cardiovascular autonomic neuropathy. Circulation. 2007;115(3):387–397.
    1. Li Z, Tang ZH, Zeng F, Zhou L. Associations between the severity of metabolic syndrome and cardiovascular autonomic function in a Chinese population. Journal of Endocrinological Investigation. 2013;36(11):993–999.
    1. Grundy SM, Hansen B, Smith SC, Jr., Cleeman JI, Kahn RA. Clinical management of metabolic syndrome: report of the American Heart Association/National Heart, Lung, and Blood Institute/American Diabetes Association conference on scientific issues related to management. Circulation. 2004;109(4):551–556.
    1. Boudina S, Abel ED. Diabetic cardiomyopathy revisited. Circulation. 2007;115(25):3213–3223.
    1. Ouwens DM, Diamant M. Myocardial insulin action and the contribution of insulin resistance to the pathogenesis of diabetic cardiomyopathy. Archives of Physiology and Biochemistry. 2007;113(2):76–86.
    1. Palmieri V, Russo C, Bella JN. Treatment of isolated left ventricular diastolic dysfunction in hypertension: reaching blood pressure target matters. Hypertension. 2010;55(2):224–225.
    1. van Dijk JG, Koenderink M, Zwinderman AH, Haan J, Kramer CGS, den Heijer JC. Autonomic nervous system tests depend on resting heart rate and blood pressure. Journal of the Autonomic Nervous System. 1991;35(1):15–24.
    1. Stella P, Ellis D, Maser RE, Orchard TJ. Cardiovascular autonomic neuropathy (expiration and inspiration ratio) in type 1 diabetesIncidence and predictors. Journal of Diabetes and its Complications. 2000;14(1):1–6.
    1. Brownlee M. The pathobiology of diabetic complications: a unifying mechanism. Diabetes. 2005;54(6):1615–1625.
    1. Witte DR, Tesfaye S, Chaturvedi N, Eaton SEM, Kempler P, Fuller JH. Risk factors for cardiac autonomic neuropathy in type 1 diabetes mellitus. Diabetologia. 2005;48(1):164–171.
    1. Axelrod S, Lishner M, Oz O. Spectral analysis of fluctuations in heart rate: an objective evaluation of autonomic nervous control in chronic renal failure. Nephron. 1987;45(3):202–206.
    1. Pop-Busui R, Kirkwood I, Schmid H, et al. Sympathetic dysfunction in type 1 diabetes: association with impaired myocardial blood flow reserve and diastolic dysfunction. Journal of the American College of Cardiology. 2004;44(12):2368–2374.

Source: PubMed

3
S'abonner